Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Multi-center, Randomized, Double Blinded, Placebo-controlled, Phase 2b/3 Clinical Trial to Evaluate the Safety and Efficacy of TPX-115 in Patients With Partial-thickness Rotator Cuff Tear

NCT06414005 is registered in ClinicalTrials.gov with Tego Science, Inc. as lead sponsor.

NCT NCT06414005
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06414005 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Multi-center, Randomized, Double Blinded, Placebo-controlled, Phase 2b/3 Clinical Trial to Evaluate the Safety and Efficacy of TPX-115 in Patients With Partial-thickness Rotator Cuff Tear
Lead sponsor
Tego Science, Inc.
Phase
Phase 2/3
Overall status
Recruiting
Start date
April 15, 2024
Completion date
January 31, 2027
Enrollment
166 (estimated)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

partial thickness rotator cuff tear